An observational study in Solid Tumors, sponsored by Caris Science, Inc.. Terminated. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-01-23.
Sponsored by Caris Science, Inc. · Observational
This data collection Registry is a multi-center, observational outcomes Database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, quality of life and outcomes of subjects utilizing Caris Molecular Intelligence™ Services for treatment of solid tumor cancer.
Caris Science, Inc. is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
All patients seen within a physician practice participating in the Registry are potential candidates if they meet the eligibility criteria requirements
Exclusion Criteria:
Documentation of the frequency of specific clinical events in relation to risk factors, diagnosis and treatments provided.
Time frame: 5 years per patient
No study locations are listed for this record.
This study is terminated, as verified in Jan 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Caris Science, Inc.